nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitiglinide—PPARG—forelimb—amyotrophic lateral sclerosis	0.108	0.192	CbGeAlD
Mitiglinide—PPARG—hindlimb—amyotrophic lateral sclerosis	0.0969	0.173	CbGeAlD
Mitiglinide—PPARG—appendage—amyotrophic lateral sclerosis	0.0831	0.148	CbGeAlD
Mitiglinide—ABCC8—brainstem—amyotrophic lateral sclerosis	0.0331	0.0591	CbGeAlD
Mitiglinide—ABCC8—Inwardly rectifying K+ channels—KCNJ10—amyotrophic lateral sclerosis	0.0289	0.0659	CbGpPWpGaD
Mitiglinide—KCNJ11—Inwardly rectifying K+ channels—KCNJ10—amyotrophic lateral sclerosis	0.0281	0.0639	CbGpPWpGaD
Mitiglinide—PPARG—embryo—amyotrophic lateral sclerosis	0.0276	0.0492	CbGeAlD
Mitiglinide—ABCC8—medulla oblongata—amyotrophic lateral sclerosis	0.0231	0.0412	CbGeAlD
Mitiglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.0229	0.0522	CbGpPWpGaD
Mitiglinide—ABCC8—spinal cord—amyotrophic lateral sclerosis	0.0206	0.0367	CbGeAlD
Mitiglinide—KCNJ11—nervous system—amyotrophic lateral sclerosis	0.0188	0.0336	CbGeAlD
Mitiglinide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.0185	0.0421	CbGpPWpGaD
Mitiglinide—KCNJ11—central nervous system—amyotrophic lateral sclerosis	0.0181	0.0323	CbGeAlD
Mitiglinide—KCNJ11—cerebellum—amyotrophic lateral sclerosis	0.0177	0.0316	CbGeAlD
Mitiglinide—ABCC8—nervous system—amyotrophic lateral sclerosis	0.0174	0.0309	CbGeAlD
Mitiglinide—PPARG—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.0169	0.0385	CbGpPWpGaD
Mitiglinide—ABCC8—central nervous system—amyotrophic lateral sclerosis	0.0167	0.0298	CbGeAlD
Mitiglinide—ABCC8—cerebellum—amyotrophic lateral sclerosis	0.0163	0.0291	CbGeAlD
Mitiglinide—KCNJ11—brain—amyotrophic lateral sclerosis	0.0144	0.0257	CbGeAlD
Mitiglinide—PPARG—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.0134	0.0304	CbGpPWpGaD
Mitiglinide—ABCC8—brain—amyotrophic lateral sclerosis	0.0133	0.0236	CbGeAlD
Mitiglinide—PPARG—nervous system—amyotrophic lateral sclerosis	0.0133	0.0236	CbGeAlD
Mitiglinide—PPARG—central nervous system—amyotrophic lateral sclerosis	0.0128	0.0227	CbGeAlD
Mitiglinide—ABCC8—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.0114	0.026	CbGpPWpGaD
Mitiglinide—PPARG—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.0112	0.0255	CbGpPWpGaD
Mitiglinide—KCNJ11—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.0111	0.0253	CbGpPWpGaD
Mitiglinide—PPARG—brain—amyotrophic lateral sclerosis	0.0101	0.0181	CbGeAlD
Mitiglinide—UGT1A3—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00689	0.0157	CbGpPWpGaD
Mitiglinide—PPARG—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.00632	0.0144	CbGpPWpGaD
Mitiglinide—UGT1A3—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00596	0.0136	CbGpPWpGaD
Mitiglinide—UGT2B7—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00586	0.0134	CbGpPWpGaD
Mitiglinide—PPARG—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.00579	0.0132	CbGpPWpGaD
Mitiglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.0053	0.0121	CbGpPWpGaD
Mitiglinide—UGT2B7—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00507	0.0116	CbGpPWpGaD
Mitiglinide—UGT1A3—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00504	0.0115	CbGpPWpGaD
Mitiglinide—ABCC8—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00499	0.0114	CbGpPWpGaD
Mitiglinide—KCNJ11—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00484	0.011	CbGpPWpGaD
Mitiglinide—ABCC8—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.0046	0.0105	CbGpPWpGaD
Mitiglinide—UGT1A3—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.00456	0.0104	CbGpPWpGaD
Mitiglinide—KCNJ11—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00447	0.0102	CbGpPWpGaD
Mitiglinide—ABCC8—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00445	0.0101	CbGpPWpGaD
Mitiglinide—PPARG—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00439	0.01	CbGpPWpGaD
Mitiglinide—KCNJ11—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00431	0.00983	CbGpPWpGaD
Mitiglinide—UGT2B7—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00429	0.00977	CbGpPWpGaD
Mitiglinide—ABCC8—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00407	0.00927	CbGpPWpGaD
Mitiglinide—KCNJ11—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00394	0.00899	CbGpPWpGaD
Mitiglinide—UGT1A3—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00389	0.00886	CbGpPWpGaD
Mitiglinide—UGT2B7—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.00388	0.00884	CbGpPWpGaD
Mitiglinide—ABCC8—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00378	0.00862	CbGpPWpGaD
Mitiglinide—ABCC8—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00378	0.00862	CbGpPWpGaD
Mitiglinide—ABCC8—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00371	0.00846	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00369	0.00841	CbGpPWpGaD
Mitiglinide—KCNJ11—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00367	0.00836	CbGpPWpGaD
Mitiglinide—KCNJ11—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00367	0.00836	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00338	0.00769	CbGpPWpGaD
Mitiglinide—ABCC8—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00337	0.00768	CbGpPWpGaD
Mitiglinide—UGT2B7—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00331	0.00753	CbGpPWpGaD
Mitiglinide—KCNJ11—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00327	0.00745	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00314	0.00715	CbGpPWpGaD
Mitiglinide—UGT1A3—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00304	0.00693	CbGpPWpGaD
Mitiglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—amyotrophic lateral sclerosis	0.00299	0.0068	CbGpPWpGaD
Mitiglinide—PPARG—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.00297	0.00678	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00295	0.00672	CbGpPWpGaD
Mitiglinide—PPARG—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.00279	0.00636	CbGpPWpGaD
Mitiglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.00277	0.00632	CbGpPWpGaD
Mitiglinide—UGT1A3—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00267	0.00608	CbGpPWpGaD
Mitiglinide—UGT1A3—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00263	0.006	CbGpPWpGaD
Mitiglinide—UGT2B7—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00259	0.00589	CbGpPWpGaD
Mitiglinide—ABCC8—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00239	0.00545	CbGpPWpGaD
Mitiglinide—PPARG—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.00237	0.0054	CbGpPWpGaD
Mitiglinide—PPARG—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.00231	0.00526	CbGpPWpGaD
Mitiglinide—ABCC8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00229	0.00523	CbGpPWpGaD
Mitiglinide—ABCC8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00229	0.00523	CbGpPWpGaD
Mitiglinide—UGT2B7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00227	0.00517	CbGpPWpGaD
Mitiglinide—UGT2B7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00224	0.0051	CbGpPWpGaD
Mitiglinide—KCNJ11—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00222	0.00507	CbGpPWpGaD
Mitiglinide—KCNJ11—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00222	0.00507	CbGpPWpGaD
Mitiglinide—PPARG—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00211	0.00482	CbGpPWpGaD
Mitiglinide—ABCC8—Metabolism—VAPA—amyotrophic lateral sclerosis	0.0021	0.00478	CbGpPWpGaD
Mitiglinide—UGT1A3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00204	0.00466	CbGpPWpGaD
Mitiglinide—UGT1A3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00204	0.00466	CbGpPWpGaD
Mitiglinide—KCNJ11—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00203	0.00463	CbGpPWpGaD
Mitiglinide—ABCC8—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00203	0.00463	CbGpPWpGaD
Mitiglinide—ABCC8—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00203	0.00463	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00202	0.00461	CbGpPWpGaD
Mitiglinide—PPARG—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.00195	0.00445	CbGpPWpGaD
Mitiglinide—ABCC8—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00195	0.00444	CbGpPWpGaD
Mitiglinide—KCNJ11—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00189	0.00431	CbGpPWpGaD
Mitiglinide—UGT1A3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00187	0.00426	CbGpPWpGaD
Mitiglinide—ABCC8—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00183	0.00418	CbGpPWpGaD
Mitiglinide—ABCC8—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00181	0.00413	CbGpPWpGaD
Mitiglinide—KCNJ11—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00178	0.00405	CbGpPWpGaD
Mitiglinide—UGT2B7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00174	0.00396	CbGpPWpGaD
Mitiglinide—UGT1A3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00174	0.00396	CbGpPWpGaD
Mitiglinide—UGT2B7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00174	0.00396	CbGpPWpGaD
Mitiglinide—PPARG—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.00168	0.00382	CbGpPWpGaD
Mitiglinide—ABCC8—Metabolism—DAO—amyotrophic lateral sclerosis	0.00166	0.00378	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00164	0.00375	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00164	0.00375	CbGpPWpGaD
Mitiglinide—UGT1A3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00163	0.00372	CbGpPWpGaD
Mitiglinide—KCNJ11—Metabolism—DAO—amyotrophic lateral sclerosis	0.00161	0.00366	CbGpPWpGaD
Mitiglinide—UGT2B7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00159	0.00362	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00153	0.00349	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism—VAPA—amyotrophic lateral sclerosis	0.0015	0.00343	CbGpPWpGaD
Mitiglinide—UGT1A3—Metabolism—DAO—amyotrophic lateral sclerosis	0.00148	0.00337	CbGpPWpGaD
Mitiglinide—UGT2B7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00148	0.00337	CbGpPWpGaD
Mitiglinide—PPARG—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.00147	0.00334	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.0014	0.00318	CbGpPWpGaD
Mitiglinide—UGT2B7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00139	0.00317	CbGpPWpGaD
Mitiglinide—PPARG—Gene Expression—FUS—amyotrophic lateral sclerosis	0.00136	0.0031	CbGpPWpGaD
Mitiglinide—PPARG—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.00132	0.00301	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00131	0.00299	CbGpPWpGaD
Mitiglinide—UGT2B7—Metabolism—DAO—amyotrophic lateral sclerosis	0.00126	0.00286	CbGpPWpGaD
Mitiglinide—ABCC8—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00126	0.00286	CbGpPWpGaD
Mitiglinide—KCNJ11—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00122	0.00278	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism—DAO—amyotrophic lateral sclerosis	0.00119	0.00271	CbGpPWpGaD
Mitiglinide—ABCC8—Metabolism—GSR—amyotrophic lateral sclerosis	0.00116	0.00264	CbGpPWpGaD
Mitiglinide—KCNJ11—Metabolism—GSR—amyotrophic lateral sclerosis	0.00112	0.00256	CbGpPWpGaD
Mitiglinide—UGT1A3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00112	0.00255	CbGpPWpGaD
Mitiglinide—PPARG—Gene Expression—RARA—amyotrophic lateral sclerosis	0.00111	0.00253	CbGpPWpGaD
Mitiglinide—UGT1A3—Metabolism—GSR—amyotrophic lateral sclerosis	0.00103	0.00236	CbGpPWpGaD
Mitiglinide—UGT2B7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000952	0.00217	CbGpPWpGaD
Mitiglinide—ABCC8—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000952	0.00217	CbGpPWpGaD
Mitiglinide—KCNJ11—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000923	0.0021	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism—PLB1—amyotrophic lateral sclerosis	0.0009	0.00205	CbGpPWpGaD
Mitiglinide—UGT2B7—Metabolism—GSR—amyotrophic lateral sclerosis	0.000879	0.002	CbGpPWpGaD
Mitiglinide—UGT1A3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000849	0.00193	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism—GSR—amyotrophic lateral sclerosis	0.000831	0.00189	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000757	0.00172	CbGpPWpGaD
Mitiglinide—UGT2B7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000722	0.00164	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000682	0.00156	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000623	0.00142	CbGpPWpGaD
Mitiglinide—PPARG—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000584	0.00133	CbGpPWpGaD
Mitiglinide—ABCC8—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000512	0.00117	CbGpPWpGaD
Mitiglinide—KCNJ11—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000496	0.00113	CbGpPWpGaD
Mitiglinide—ABCC8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00047	0.00107	CbGpPWpGaD
Mitiglinide—UGT1A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000456	0.00104	CbGpPWpGaD
Mitiglinide—KCNJ11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000456	0.00104	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000427	0.000972	CbGpPWpGaD
Mitiglinide—UGT1A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000419	0.000955	CbGpPWpGaD
Mitiglinide—PPARG—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000419	0.000955	CbGpPWpGaD
Mitiglinide—UGT2B7—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000388	0.000884	CbGpPWpGaD
Mitiglinide—ABCC8—Metabolism—APOE—amyotrophic lateral sclerosis	0.000387	0.000882	CbGpPWpGaD
Mitiglinide—PPARG—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.000376	0.000858	CbGpPWpGaD
Mitiglinide—KCNJ11—Metabolism—APOE—amyotrophic lateral sclerosis	0.000375	0.000855	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000367	0.000836	CbGpPWpGaD
Mitiglinide—UGT2B7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000356	0.000812	CbGpPWpGaD
Mitiglinide—UGT1A3—Metabolism—APOE—amyotrophic lateral sclerosis	0.000345	0.000786	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000337	0.000768	CbGpPWpGaD
Mitiglinide—UGT2B7—Metabolism—APOE—amyotrophic lateral sclerosis	0.000293	0.000668	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism—APOE—amyotrophic lateral sclerosis	0.000277	0.000632	CbGpPWpGaD
Mitiglinide—ABCC8—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000265	0.000604	CbGpPWpGaD
Mitiglinide—KCNJ11—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000257	0.000586	CbGpPWpGaD
Mitiglinide—UGT1A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000236	0.000539	CbGpPWpGaD
Mitiglinide—UGT2B7—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000201	0.000458	CbGpPWpGaD
Mitiglinide—PPARG—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.00019	0.000433	CbGpPWpGaD
